![Yannick Vancoppenolle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yannick Vancoppenolle
Director/Board Member at ViroVet NV
Network origin in Yannick Vancoppenolle first degree
Entity | Entity type | Industry | |
---|---|---|---|
ViroVet NV
![]() ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Sopartec SA
![]() Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium.
5
| Subsidiary | Investment Managers | 5 |
Botalys SA
![]() Botalys SA Agricultural Commodities/MillingProcess Industries Botalys SA engages in the development and operation of bioreactors to cultivate medicinal plants. It specializes in biotechnology, plant extract, hairy roots. The company was founded by Pierre-Antoine Mariage in 2011 and is headquartered in Ghislenghien, Belgium.
4
| Holding Company | Agricultural Commodities/Milling | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yannick Vancoppenolle via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Public Communications Contact | |
PHIBRO ANIMAL HEALTH CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Royal College of Veterinary Surgeons
![]() Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Capricorn Partners NV
![]() Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
SOCIÉTÉ FINANCIÈRE DES SUCRES SA | Agricultural Commodities/Milling | Director/Board Member | |
Elanco Tiergesundheit AG
![]() Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | President | |
Aveve NV
![]() Aveve NV Agricultural Commodities/MillingProcess Industries Aveve NV supplies agricultural and horticultural products. The firm specializes in farming industry, retail, agriculture, horticulture and animal feed. The company was founded by John F. Mellaerts on July 20, 1890 and is headquartered in Leuven, Belgium. | Agricultural Commodities/Milling | Director/Board Member | |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Participatiemaatschappij Vlaanderen NV
![]() Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
Pharmaq AS
![]() Pharmaq AS Pharmaceuticals: MajorHealth Technology PHARMAQ AS operates as a veterinary pharmaceutical company. It provides health products to the global aquaculture industry. The company was founded on July 23, 2004 and is headquartered in Overhalla, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Compagnie Le Zoute NV
![]() Compagnie Le Zoute NV Hotels/Resorts/Cruise linesConsumer Services Compagnie Le Zoute NV is a Belgian company that operates hotels. The private company is based in Knokke-Heist, Belgium and has subsidiaries in Belgium. The company was founded in 1931. | Hotels/Resorts/Cruise lines | Director/Board Member | |
COMPAGNIE HET ZOUTE NV | Real Estate Development | Director/Board Member | |
Université de Bordeaux | College/University | Doctorate Degree | |
Ghent University | College/University | Doctorate Degree | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Université Catholique de Louvain | College/University | Undergraduate Degree Masters Business Admin | |
ANIMALCARE GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Biotechnology | Director/Board Member | |
Solvay Pharmaceuticals SA
![]() Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Pharmaceuticals: Major | Public Communications Contact | |
reMYND NV
![]() reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Centre d'entreprises et d'innovation de Louvain la Neuve NV
![]() Centre d'entreprises et d'innovation de Louvain la Neuve NV Miscellaneous Commercial ServicesCommercial Services Centre d'Entreprise et d'Innovation de Louvain-La-Neuve NV provides advice and consultancy services for small and medium sized businesses. The firm is a launch base for start-ups and supports the created business during the first years of development. The company was founded on April 22, 2004 and is headquartered in Louvain-La-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cybelle NV | Director/Board Member | ||
Etablissementen Adriaens NV
![]() Etablissementen Adriaens NV Food: Meat/Fish/DairyConsumer Non-Durables Etablissementen Adriaens SA engages in the operation of a slaughterhouse for pork and beef processing. The company was founded on November 17, 1960 and is headquartered in Zottegem, Belgium. | Food: Meat/Fish/Dairy | Director/Board Member | |
Pharmaq Holding AS
![]() Pharmaq Holding AS Financial ConglomeratesFinance Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway. | Financial Conglomerates | Director/Board Member | |
Nexvet Australia Pty Ltd.
![]() Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chairman | |
Ifast NV
![]() Ifast NV Miscellaneous Commercial ServicesCommercial Services Ifast NV develops and commercializes intellectual property, technology and know-how related to the organoleptic and functional properties of foods and beverages. It offers services to the corporate and public sectors. The company was founded by Pascal Mertens in 2012 and is headquartered in Roosdaal, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Diversigen, Inc.
![]() Diversigen, Inc. Miscellaneous Commercial ServicesCommercial Services Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Royal Dick School of Veterinary Studies | College/University | Undergraduate Degree | |
DName-iT NV
![]() DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | Biotechnology | Director/Board Member | |
Porphyrio NV
![]() Porphyrio NV Packaged SoftwareTechnology Services Porphyrio NV engages in the development of management software solutions for the agricultural sector. It offers Smart Farm Assistant , Smart Broiler Chain Optimizer, Lay-Insight, and Broiler-Insight. The company was founded by Bart Kemps and Kristof Mertens on August 03, 2013 and is headquartered in Herent, Belgium. | Packaged Software | Chairman | |
Nuritas Ltd.
![]() Nuritas Ltd. Miscellaneous Commercial ServicesCommercial Services Nuritas Ltd. provides bioinformatics technology services. It offers products for human health and nutrition, cosmetics and personal care, animal health and nutrition. The firm’s disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. The company was founded by Nora Khaldi and is headquartered in Dublin, Ireland. | Miscellaneous Commercial Services | Chairman | |
Caloritum NV
![]() Caloritum NV Industrial ConglomeratesProducer Manufacturing Caloritum NV offers innovative technology to industrial customers. The firm provides transform wasted heat into useful process heat and reduces the total energy bill by saving fossil fuels and CO2 emissions. The company was founded by Wouter Ducheyne and Christian Heeren in 2012 and is headquartered in Antwerp, Belgium. | Industrial Conglomerates | Director/Board Member | |
Stonehaven Consulting AG
![]() Stonehaven Consulting AG Miscellaneous Commercial ServicesCommercial Services Part of SC Group, Inc., Stonehaven Consulting AG is a Swiss company that provides life sciences management consulting services. The company is based in Frauenfeld, Switzerland. The company was founded in 2015 by George C. Gunn, Paddy Holahan. The CEO is Matthias Manuel Hofer. | Miscellaneous Commercial Services | Founder | |
Aphea.Bio SA
![]() Aphea.Bio SA BiotechnologyHealth Technology Aphea.Bio SA engages in research and development of biotechnology and agricultural products. It develops next generation biopesticides and biostimulants based on natural microorganisms. The company was founded by Isabel Vercauteren and Steven Vandenabeele in December 5, 2016 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Syndesi Therapeutics SA
![]() Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
THERAVET SA | Miscellaneous Commercial Services | Director/Board Member | |
ArtiQ NV
![]() ArtiQ NV Packaged SoftwareTechnology Services ArtiQ NV engages in the design and manufacture of respiratory medicine, medical devices, and artificial intelligence. The company was founded by Marko Topalovic, Bart Swaelens, Wim Janssens and Marc Decramer in 2019 and is headquartered in Leuven, Belgium. | Packaged Software | Chairman | |
Pulsify Medical BV
![]() Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Medical Specialties | Director/Board Member | |
AnimAb BV
![]() AnimAb BV BiotechnologyHealth Technology AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020. | Biotechnology | General Counsel | |
Flanders Vaccine | Director/Board Member | ||
Aktiefinvest CVBA
![]() Aktiefinvest CVBA Real Estate DevelopmentFinance Part of Maatschappij voor Roerend Bezit van de Boerenbond CVBA, Aktiefinvest CVBA is a Belgian company that provides real estate services. The company is based in Louvain, Belgium and was founded in 1990. | Real Estate Development | Director/Board Member |
Statistics
International
Belgium | 32 |
United States | 5 |
Switzerland | 5 |
United Kingdom | 4 |
Ireland | 3 |
Sectoral
Health Technology | 20 |
Commercial Services | 10 |
Finance | 7 |
Consumer Services | 7 |
Process Industries | 4 |
Operational
Director/Board Member | 47 |
Founder | 9 |
Chairman | 9 |
Corporate Officer/Principal | 8 |
Private Equity Investor | 6 |
Most connected contacts
- Stock Market
- Insiders
- Yannick Vancoppenolle
- Company connections